CJC-1295 and Ipamorelin peptide blend is a synthetic research formulation studied in growth hormone secretagogue pathways. CJC-1295 is a modified GHRH analog with extended stability in plasma. Ipamorelin is a selective pentapeptide studied for interaction with the GHS-R1a receptor. Together, this blend is examined for pituitary signaling dynamics, growth hormone pulsatility, and metabolic research applications. Supplied strictly for laboratory and…
CJC-1295 DAC is a synthetic 29 amino acid peptide designed as a long acting growth hormone releasing hormone analog. The DAC modification supports extended stability and prolonged activity in research settings. This peptide is studied for sustained growth hormone release, IGF-1 signaling, and endocrine pathway modeling. Supplied strictly for laboratory and educational research use.
